Fontan Circulation
9
4
4
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 9 trials
100.0%
+13.4% vs benchmark
11%
1 trials in Phase 3/4
33%
1 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 3 completed trials
Clinical Trials (9)
Muscle Function in Patients With Single-chamber Heart
Feasibility of Non-invasive Hemodynamic Assessment by 5D Flow in Congenital Heart Disease
Venous Compression in Fontan
CAMEO-FONTAN -Dapagliflozin in the Failing Fontan Circulation
Gut, Inflammation and Nutrition in Adult Patients After Fontan Operation
IMProving DRug Dosing and Outcomes for Single VEntricle Patients With Fontan Associated Liver Disease
Fontan Circulation and Reproductive Health in a National Swedish Cohort
Impact of Therapy Using Colesevelam Treatment Reducing Bile Acids in Patients With Fontan Circulation.
The Effects of Sildenafil on Exercise Function and Capacity in Patients With Fontan Circulation